Published in Int J Dermatol on December 01, 2010
Ectopic expression of cancer-testis antigens in cutaneous T-cell lymphoma patients. Clin Cancer Res (2014) 0.90
Hypopigmented mycosis fungoides: a review of its clinical features and pathophysiology. An Bras Dermatol (2014) 0.89
Cutaneous T-cell lymphoma in asians. ISRN Dermatol (2012) 0.87
Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines. Cell Cycle (2014) 0.86
Mycosis fungoides in Iranian population: an epidemiological and clinicopathological study. J Skin Cancer (2015) 0.85
Demographic patterns of cutaneous T-cell lymphoma incidence in Texas based on two different cancer registries. Cancer Med (2015) 0.83
Primary cutaneous lymphomas: A clinical and histological study of 99 cases in Isfahan, Iran. J Res Med Sci (2015) 0.80
Characteristics of Primary Cutaneous T-Cell Lymphoma in Iran: A 10-Year Retrospective Study. Int Sch Res Notices (2014) 0.79
Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells (2010) 3.24
Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (ECM1). Hum Mol Genet (2002) 2.41
Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma. J Clin Oncol (2010) 2.33
A call for the development and implementation of a targeted national melanoma screening program. Arch Dermatol (2006) 2.29
Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am J Hum Genet (2003) 1.94
Mutations in PYCR1 cause cutis laxa with progeroid features. Nat Genet (2009) 1.89
Melanoma incidence and mortality among US whites, 1969-1999. JAMA (2002) 1.74
Screening, early detection, and trends for melanoma: current status (2000-2006) and future directions. J Am Acad Dermatol (2007) 1.74
Temporal case clustering in pityriasis rosea: a regression analysis on 1379 patients in Minnesota, kuwait, and diyarbakir, Turkey. Arch Dermatol (2005) 1.64
Identical glycine substitution mutations in type VII collagen may underlie both dominant and recessive forms of dystrophic epidermolysis bullosa. Acta Derm Venereol (2011) 1.46
RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients. Transfusion (2003) 1.46
Characteristics associated with use or intention to use indoor tanning among adolescents. Arch Pediatr Adolesc Med (2004) 1.35
Selection criteria for genetic assessment of patients with familial melanoma. J Am Acad Dermatol (2009) 1.30
Compliance with restrictions on sale of indoor tanning sessions to youth in Minnesota and Massachusetts. J Am Acad Dermatol (2006) 1.20
Further characterization of ATP6V0A2-related autosomal recessive cutis laxa. Hum Genet (2012) 1.15
Prevalence of viral markers among first-time Arab blood donors in Kuwait. Transfusion (2005) 1.14
Maternal/female caregiver influences on adolescent indoor tanning. J Adolesc Health (2004) 1.13
Time for the national legislation of indoor tanning to protect minors. Arch Dermatol (2003) 1.11
Frequency of red blood cell alloantibody in Kuwaiti population. Med Princ Pract (2005) 1.03
The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985-1999. J Am Acad Dermatol (2003) 1.00
Mycosis fungoides in Arab children and adolescents: a report of 36 patients from Kuwait. Pediatr Dermatol (2010) 0.98
Clinical, immunologic and genetic profiles of DOCK8-deficient patients in Kuwait. Clin Immunol (2012) 0.97
Increased cancer risk for individuals with a family history of prostate cancer, colorectal cancer, and melanoma and their associated screening recommendations and practices. Cancer Causes Control (2007) 0.95
Sézary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC). J Am Acad Dermatol (2010) 0.94
Factors related to the presentation of thin and thick nodular melanoma from a population-based cancer registry in Queensland Australia. Cancer (2009) 0.94
Sun care advertising in popular U.S. magazines. Am J Health Promot (2006) 0.93
Cutaneous Rosai-Dorfman disease: histopathological presentation as inflammatory pseudotumor. A literature review. Acta Derm Venereol (2002) 0.89
Impact of next generation sequencing on diagnostics in a genetic skin disease clinic. Exp Dermatol (2013) 0.88
Skin manifestations in primary immunodeficient children. Pediatr Dermatol (2011) 0.88
Nail psoriasis treated with pulse dye laser. Indian J Dermatol (2013) 0.87
Clinically meaningful reduction in pruritus in patients with cutaneous T-cell lymphoma treated with romidepsin. Leuk Lymphoma (2012) 0.86
Homozygous mutations in the 5' region of the JUP gene result in cutaneous disease but normal heart development in children. J Invest Dermatol (2010) 0.85
Noninfectious cutaneous granulomas in primary immunodeficiency disorders: report from a national registry. Am J Dermatopathol (2014) 0.85
Successful adjuvant treatment of recalcitrant mucous membrane pemphigoid with anti-CD20 antibody rituximab. J Drugs Dermatol (2007) 0.84
Should the skin cancer examination be taught in medical school? Arch Dermatol (2002) 0.83
Lenalidomide-induced purpuric eruption: a new adverse cutaneous reaction. J Am Acad Dermatol (2011) 0.83
Coexistence of pemphigus vulgaris with systemic lupus erythematosus. Int J Dermatol (2004) 0.82
Frontiers in cancer prevention research. Cancer Res (2003) 0.82
Progression of classic Kaposi's sarcoma with rituximab. J Am Acad Dermatol (2005) 0.82
Targeting events in melanoma carcinogenesis for the prevention of melanoma. Expert Rev Anticancer Ther (2006) 0.82
Genetic analysis of interleukin-1 receptor antagonist and interleukin-1β single-nucleotide polymorphisms C-511T and C+3953T in alopecia areata: susceptibility and severity association. Clin Exp Med (2013) 0.81
Mirtazapine and gabapentin for reducing pruritus in cutaneous T-cell lymphoma. J Am Acad Dermatol (2006) 0.81
Enacting legislation to restrict youth access to tanning beds: a survey of advocates and sponsoring legislators. J Am Acad Dermatol (2010) 0.80
Well-differentiated angiosarcoma of the scalp: an unusual clinical presentation. J Am Acad Dermatol (2005) 0.79
Genetic evidence for the involvement of NOTCH4 in rheumatoid arthritis and alopecia areata. Immunol Lett (2013) 0.79
Complete response of metastatic malignant hidradenocarcinoma to capecitabine treatment. Arch Dermatol (2011) 0.79
Anaplastic Kaposi's sarcoma: an uncommon histologic phenotype with an aggressive clinical course. J Cutan Pathol (2009) 0.79
Hypopigmented T-cell dyscrasia evolving to hypopigmented mycosis fungoides during etanercept therapy. J Am Acad Dermatol (2008) 0.78
Susceptible and protective endothelial nitric oxide synthase gene polymorphism in alopecia areata in the Kuwaiti population. Autoimmunity (2008) 0.78
Assessment of delayed reporting of mycosis fungoides and Sezary syndrome in the United States. Arch Dermatol (2008) 0.78
Adult cutaneous Langerhans cell histiocytosis responsive to topical imiquimod. J Am Acad Dermatol (2006) 0.77
Keutel syndrome with overlapping features of cutis laxa: a new variant. Am J Med Genet A (2006) 0.77
Dermatofibrosarcoma protuberans arising in the context of Shwachman-Diamond syndrome. Pediatr Dermatol (2010) 0.76
Benign familial pemphigus (Hailey-Hailey disease) responsive to low dose cyclosporine. Indian J Dermatol Venereol Leprol (2010) 0.76
Thalidomide in mycosis fungoides. J Am Acad Dermatol (2005) 0.76
Unilesional (segmental) mycosis fungoides presenting in childhood. Pediatr Dermatol (2004) 0.76
Novel TGM5 mutations in acral peeling skin syndrome. Exp Dermatol (2015) 0.76
Results of a phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma. Cancer (2007) 0.76
Thin melanomas and regression, thick melanomas and older men: prognostic implications and perspectives on secondary prevention. Arch Dermatol (2002) 0.75
Sentinel lymph node biopsy for a squamoid eccrine carcinoma with lymphatic invasion. Dermatol Surg (2007) 0.75
Lipoid proteinosis: a follow-up comment. Pediatr Dermatol (2002) 0.75
Paraneoplastic pemphigus in association with B-cell lymphocytic leukemia and hepatitis C: favorable response to intravenous immunoglobulins and prednisolone. Int J Dermatol (2007) 0.75
Measuring HRQOL in patients with cutaneous T-cell lymphoma undergoing therapy with oral bexarotene and extracorporeal photopheresis. Arch Dermatol (2007) 0.75
A 26-year-old woman with a rash on her extremities. Clin Infect Dis (2006) 0.75
Case reports: nodular vasculitis responsive to mycophenolate mofetil. J Drugs Dermatol (2007) 0.75
What's your assessment? Invasive moderately differentiated squamous cell carcinoma. Dermatol Nurs (2009) 0.75
Kyrle's disease in a patient with chronic renal failure. Indian J Dermatol Venereol Leprol (2017) 0.75
TNF-α inhibitor (adalimumab) induced psoriasis: a case report. Australas J Dermatol (2012) 0.75
Transformation in mycosis fungoides: the role of methotrexate. J Cutan Med Surg (2002) 0.75
Ehlers- Danlos Syndrome. Indian J Dermatol Venereol Leprol (2017) 0.75
Lymphomatoid contact dermatitis to baby wipes. Arch Dermatol (2010) 0.75
Extensive Bilateral Symmetrical Fixed Drug Eruption. Indian J Dermatol Venereol Leprol (2017) 0.75
Self-healing juvenile cutaneous mucinosis manifesting with subcutaneous nodules. Indian J Dermatol Venereol Leprol (2010) 0.75
Extensive postzygotic mosaicism for a novel keratin 10 mutation in epidermolytic ichthyosis. Acta Derm Venereol (2014) 0.75
Sun protection factor content and warning statements for sunless tanning products: an examination of retail outlets and the Internet. J Am Acad Dermatol (2005) 0.75
Phacomatosis pigmentovascularis: Report of four new cases. Indian J Dermatol Venereol Leprol (2016) 0.75
Macrophage-rich epithelioid angiosarcoma mimicking malignant melanoma. J Cutan Pathol (2006) 0.75
Infliximab as a therapy for idiopathic hypereosinophilic syndrome. Arch Dermatol (2007) 0.75
Herpes folliculitis masquerading as cutaneous lymphoma. Am J Dermatopathol (2013) 0.75
What's your assessment? Primary melanoma arising in association with a blue nevus. Dermatol Nurs (2008) 0.75
Epidermotropic metastatic mucoepidermoid carcinoma. Am J Dermatopathol (2010) 0.75